Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer

Clinical Cancer Research

Volumn 5, Issue 10 SUPPL., 1999, Pages

  Stein, Rhona ^a   Juweid, Malik ^a   Zhang, Cun Hui ^b   Goldenberg, David M ^a  

^a GARDEN STATE CANCER CENTER   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY Y 90; DOXORUBICIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MN 14; PACLITAXEL; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; THYROID MEDULLARY CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, MEDULLARY; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PACLITAXEL; RADIOIMMUNOTHERAPY; THYROID NEOPLASMS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; YTTRIUM RADIOISOTOPES;

EID: 0032697130     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Norton, J. A., Levin, B., and Jensen, R. Cancer of the endocrine system. In: V. T. DeVita, S. Hellman, and S. A., Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 1333-1435. New York: J. B. Lippincott Co., 1989.
2. Cance, W. G., and Wells, S. A. J. Multiple endocrine neoplasia type IIa. Curr. Prob. Surg., 22: 1-56, 1985.
3. O'Bryan, R. M., Baker, L. H., Gottlieb, J. E., Rivkin, S. E., Balcerzak, S. P., Grumet, G. N., Salmon, S. E., Moon, T. E., and Hoogstraten, B. Dose response evaluation of Adriamycin in human neoplasia. Cancer (Phila.), 39: 1940-1948, 1977.
4. Burgess, M. A., and Hill, C. S. J. Chemotherapy in the management of thyroid cancer. In: L. D. Greenfield (ed.), Thyroid Cancer, pp. 233-246. West Palm Beach, FL: CRC Press, 1978.
5. Husain, M., Alsever, R. N., Lock, J. P.. George, W. F., and Katz, F. H. Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy. Horm. Res., 9: 22-25, 1978.
6. Leight, G. S., Farrell, R. E., Wells, S. A., and Falletta, J. M. Effect of chemotherapy on calcitonin (CT) levels in patients with metastatic medullary thyroid carcinoma (MTC). Proc. Am. Assoc. Cancer Res., 21: 155, 1980.
7. Harada, T., Shimaoka, K., Mimura, K., and Ito, K. Chemotherapy for thyroid cancer. In: M. Andreoli, F. Monaco, and J. Robbins (eds.), Advances in Thyroid Neoplasia, pp. 347-352. Rome: Field Educational Italia, 1981.
8. Shimaoka, K., Schoenfield, D. A., DeWys, W. D., Creech, R. H., and DeConti, R. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer (Phila.), 56: 2155-2160, 1985.
9. 90Y labeled MAbs. Cancer Biother. Radiopharm., 14: 37-47, 1999.
10. Juweid, M., Sharkey, R. M., Behr, T., Swayne, L. C., Herskovic, T., Pereira, M., Rubin, A. D., Hanley, D., Dunn, R., Siegel, J., and Goldenberg, D. M. Radioimmunotherapy of medullary thyroid carcinoma with I-131-labeled anti-CEA antibodies. J. Nucl. Med., 37: 905-911, 1996.
11. Juweid, M., Sharkey, R. M., Behr, T., Swayne, L. C., Rubin, A. D., Hanley, D., Markowitz, A., Siegel, J., and Goldenberg, D. M. Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with I-131-labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res., 55: 5946s-5951s, 1995.
12. DeNardo, S. J., Kukis, D. L., Kroger, L. A., O'Donnell, R. T., Lamborn, K. R., Miers, L. A., DeNardo, D. G., Meares, C. F., and DeNardo, G. L. Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts. Proc. Natl. Acad. Sci. USA. 94: 4000-4004, 1997.
13. Behr, T. M., Wulst, E., Radetzky, S., Blumenthal, R. D., Dunn, R. M., Gratz, S., Rave-Fränk, M., Schmidberger, H., Raue, F., and Becker, W. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Cancer Res., 57: 5309-5319, 1997.
14. 131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil). Cancer Res., 57: 2181-2186, 1997.
15. Kim, J. H., and Leeper, R. D. Combination Adriamycin and radiation therapy for locally advanced carcinoma of the thyroid gland. Radiat. Oncol. Biol. Phys., 9: 565-567, 1983.
16. Kim, J. H., and Leeper, R. D. Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination Adriamycin and radiation therapy. Cancer (Phila.), 52: 954-957, 1983.
17. Bonner, J. A., and Lawrence, T. S. Doxorubicin decreases the repair of radiation-induced DNA damage. Int. J. Radiat. Biol., 57: 55-64, 1990.
18. Nelkin, B. D., Rosenfeld, K. I., de Bustros, A., Leong, S. S., Roos, B. A., and Baylin, S. B. Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide. Biochem. Biophys. Res. Commun., 123: 648-655, 1984.
19. Hansen, H. J., Goldenberg, D. M., Newman, E. S., Grebenau, R., and Sharkey, R. M. Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer (Phila.), 71: 3478-3485, 1993.
20. Motta-Hennessy, C. Sharkey, R. M., and Goldenberg, D. M. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. J. Nucl. Med., 31: 1510-1519, 1990.
21. Blumenthal, R. D., Sharkey, R. M., and Goldenberg, D. M. Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor intervention to reduce myelosuppression. J. Natl. Cancer Inst., 84: 399-407, 1992.
22. Durand, R. E., and LePard, N. E. Modulation of tumor hypoxia by conventional chemotherapeutic agents. J. Radiat. Oncol. Biol. Phys., 29: 481-486, 1994.
23. Durand, R. E., and LePard, N. E. Tumour blood flow influences combined radiation and doxorubicin treatments. Radiother. Oncol., 42: 171-179, 1997.
24. Stein, R., Goldenberg, D. M., Thorpe, S. R., and Mattes, M. J. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. Cancer Res., 55: 3132-3193, 1995.
25. Siegel, J. A., and Stabin, M. G. Absorbed fractions for electrons and beta particles in spheres of various sizes. J. Nucl. Med., 35: 152-156, 1994.
26. Peto, R., and Peto, J. Asymptotically efficient rank invariant test procedures (with discussion). J. R. Statist. Soc. A. 135: 195-206, 1972.
27. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
28. Sgouros, G. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations. J. Nucl. Med., 34: 689-694, 1993.